P16: Research Funding – new paradigms for a broken system?

Thursday, November 21, 2013 - 3:30pm to 5:00pm
Organizer: 
Samuel Lunenfeld Research Institute

The various tools by which research is funded internationally are under duress. Various agencies, whether governmental, NGO or Foundations are re-evaluating how and what research they fund. Peer review is under extreme pressure due to diminishing pay-lines and the duration and required investments in trainees is grossly out of proportion with available opportunities. Yet, the "pull" issues remain the same: a desire to improve health, develop new technologies, train an educated/skilled workforce. The problems lie in the distinct agendas, assumptions and expectations of the funders of science (inc. governments) and the scientific community. Topics for this panel will include: (1) discussion of the various reforms proposed by agencies and their rational, (2) what the funder wants, (3) what the scientist hears, (4) bridging the gap in a constructive manner. Subthemes for discussion will include: emergence of leverage/co-funding models, charitable repositioning (demands), rush to translate/commercialise, burden of reporting, how best to measure performance (and which metrics to use), the expectations of the public and how to communicate/involve the public.

Speakers

Director of Research
Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital

Director of Research at the Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital running a basic science research lab probing the molecular mechanisms underlying common diseases such as diabetes, Alzheimers disease and breast cancer. Chairs two grant review panels for the Canadian Cancer Society and the Canadian Institutes of Health Research.

Vice-President of Research
Canadian Institutes of Health Research

Vice-President of Research, Canadian Institutes of Health Research and researcher at the University of Toronto specializing in arthritis and bone health. Is leading the drive to major reforms of the CIHR funding mechanisms and review processes and is internationally known for her work on musculoskeletal biology.

Vice President of Research
Canadian Cancer Society Research Institute

Currently Vice President of Research at the Canadian Cancer Society Research Institute and responsible for overseeing adjudication and distribution of ~$45 million of donor funding for research. Has overseen a major transition in CCSRI funding programs in past three years.

Professor of Molecular Genetics
University of British Columbia

Professor of Molecular Genetics at the University of British Columbia and yeast geneticist focused on chromosomal integrity. Member of CIHR working group on program reforms and member of national and international grant panels.

Executive Director
Global Alliance for sharing of genomic and clinical data at the Ontario Institute for Cancer Research

Past President of both the Heart and Stroke Foundation and Canadian Cancer Society (Ontario and National). Currently acting Executive Director of the Global Alliance for sharing of genomic and clinical data at the Ontario Institute for Cancer Research and Chair of the Board of the Health Technology Exchange.